Results
Filtros
CRF-SP warns of risk of setback and legal uncertainty in the review of the Cannabis regulation
According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites
Anvisa Regulatory Agenda 2026 - 2027 opens space for society suggestions, including on cannabis
Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium
The Medicinal Cannabis Market in Brazil Could Reach R$ 15 Billion with New Anvisa Regulation
Projections indicate accelerated growth of the medicinal cannabis market by 2034, driven by regulatory changes and expanded therapeutic applications
Anvisa to vote on draft regulation on the cultivation of cannabis this Wednesday (14)
Draft discussed in a meeting with a YouTube broadcast contains points on THC limit, Sanitary control execution, import and export, destination of the cultivated plant among others
Countdown: government has until September 30th to publish regulation on cannabis cultivation
Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan
Associations may have more space in the debate on the regulation of cannabis cultivation in Brazil
Entrepreneur Fabrício Penafiel considers the inclusion of practical experience of producers in the proposal, with a deadline set for September 30th, a historic opportunity.
Anvisa to decide today the future of RDC 327 in a meeting that could redefine rules for cannabis products in Brazil
Norm that regulates manufacturing, importation, prescription, and inspection may be entirely revoked and replaced by a new regulatory framework; decision will be made at the Collegiate Board meeting.
Anvisa suspends review of RDC 327 after director's request for further analysis
Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Anvisa completes 23 years: a timeline about the agency and medicinal cannabis
01/26/2022On the anniversary of the National Health Surveillance Agency (Anvisa), learn about the evolution of the medicinal use of cannabis over the 23 years since the agency was created
Cannabis ruderalis: origin, effects, and benefits of the lesser-known subspecies
Discover what cannabis ruderalis is, its main characteristics, uses, effects, and why it arouses the interest of growers and researchers
Colombian researchers develop method to separate THC from cannabis while preserving other cannabinoids
New technique uses centrifugal partition chromatography and achieves 85% CBD in a product with only 0.02% THC
Cannabis, Anxiety, and Their Complex Relationships
A paradox of cause and cure marks the union between cannabis and anxiety. Why does this happen?
France extends medicinal cannabis program, but definitive regulation remains undefined
Ministry of Health extends deadline to avoid treatment interruptions in 2026; industry demands permanent law already validated by the EU
Medicinal Cannabis Opens Paths to a Lighter Aging Process
Between science and life stories, cannabis emerges as an ally in healthy aging, bringing relief, balance, and new ways of experiencing time